Journal article
Tumor Necrosis Factor Inhibitor Dose Reduction for Axial Spondyloarthritis: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
Abstract
OBJECTIVE: The present study was undertaken to investigate the effectiveness and safety of dose reduction of tumor necrosis factor inhibitor (TNFi) therapy in the treatment of axial spondyloarthritis (SpA) compared to usual care.
METHODS: We searched the Cochrane Central Register of Controlled Trials, Embase, Medline, and trial registries. We screened, extracted data, and assessed risk of bias in duplicate. Data were pooled using random-effects …
Authors
Lawson DO; Eraso M; Mbuagbaw L; Joanes M; Aves T; Leenus A; Omar A; Inman RD
Journal
Arthritis Care & Research, Vol. 73, No. 6, pp. 861–872
Publisher
Wiley
Publication Date
June 2021
DOI
10.1002/acr.24184
ISSN
2151-464X